Contraception Clinical Trial
Official title:
Peer Influence on Intrauterine Contraceptive Behavior and Attitudes in an Online Social Community
Verified date | March 2019 |
Source | University of California, San Francisco |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will look at women's social communication about IUDs (intrauterine devices) and their attitudes and behavior related to IUD use. The researchers will design an online community where women can talk to each other about their experiences with birth control. We will examine whether social exposure to IUD users in this setting is associated with change in attitudes and behavior among women who have never had an IUD.
Status | Completed |
Enrollment | 630 |
Est. completion date | July 2016 |
Est. primary completion date | July 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: Non-IUC users: - Women - Age 18 - 45 - Sexually active with men - Do not want to get pregnant in the next year - Want to learn more about different birth control methods IUC users - Women - Age 18-45 - Currently uses IUC (Paragard, Mirena, or Skyla) Exclusion Criteria: Non-IUC users - Previous IUC use - Not able to become pregnant IUC users -Using IUC for other reason, and not pregnancy prevention |
Country | Name | City | State |
---|---|---|---|
United States | University of Pennsylvania, Annenberg School of Communication | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco | University of Pennsylvania, William and Flora Hewlett Foundation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of Participants Reporting IUC Use | Self-reported use of IUC in post-survey | 12 days post-baseline | |
Secondary | Mean Change in Attitude About Hormonal IUC as Method for Self Between Pre-survey and Post-survey | Mean difference of responses to scale in pre- and post-surveys asking participants to rate hormonal IUC as a contraceptive method for themselves, with 0=terrible method and 10=great method | 12 days post-baseline | |
Secondary | Mean Change in Attitude About Hormonal IUC as Method for Women in General Between Pre-survey and Post-survey | Responses to scale in pre- and post-surveys asking participants to rate hormonal IUC as a contraceptive method for women in general, with 0=terrible method and 10=great method | 12 days post-baseline | |
Secondary | Mean Change in Attitude About Non-hormonal IUC as Method for Self Between Pre-survey and Post-survey | Responses to scale in pre- and post-surveys asking participants to rate non-hormonal IUC as a contraceptive method for themselves, with 0=terrible method and 10=great method | 12 days post-baseline | |
Secondary | Mean Change in Attitude About Non-hormonal IUC as Method for Women in General Between Pre-survey and Post-survey | Responses to scale in pre- and post-surveys asking participants to rate non-hormonal IUC as a contraceptive method for women in general, with 0=terrible method and 10=great method | 12 days post-baseline | |
Secondary | Number of Participants With Responses Indicating Knowledge of IUC Safety | Response on 5-point Likert scale of agreement in post-survey on IUC safety. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5. | 12 days post-baseline | |
Secondary | Number of Participants With Responses Indicating Knowledge of IUC Effectiveness | Response on 5-point Likert scale of agreement in post-survey on IUC effectiveness. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5. | 12 days post-baseline | |
Secondary | Number of Participants With Responses Indicating Knowledge of IUC Being More Effective Than Birth Control Pill | Correct response to post-survey item asking whether IUC is more, less, or as effective as the birth control pill (correct response: more effective). | 12 days post-baseline | |
Secondary | Number of Participants Reporting Informational Support (Receiving New Information From Birth Control Connect) | Response on 5-point Likert scale of agreement in post-survey on whether Birth Control Connect group gave participants information on IUC they didn't have before. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5. | 12 days post-baseline | |
Secondary | Number of Participants Reporting Informational Support (Better Idea of What IUC Would be Like) | Response on 5-point Likert scale of agreement in post-survey on whether Birth Control Connect gave them a better idea of what using IUC would be like. Dichotomized as 4 or 5 (Agree or strongly agree) vs. 1, 2, or 3 (Strongly disagree, disagree, or neither agree nor disagree). Outcome is count of participants responding 4 or 5. | 12 days post-baseline | |
Secondary | Number of Participants Reporting Information-seeking on Internet | Report (Yes/No) in post-survey of whether participant had looked on the Internet (outside of Birth Control Connect) for information on IUC since study start. Outcome is count of participants reporting yes. | 12 days post-baseline | |
Secondary | Number of Participants Reporting Information-seeking From a Health Care Provider | Report (Yes/No) in post-survey of whether participant had consulted a health care provider about IUC since study start. Outcome is count of participants reporting yes. | 12 days post-baseline | |
Secondary | Number of Participants Reporting Information-seeking From Peers | Report (Yes/No) in post-survey of whether participant had talked to women they know about IUC since study start. Outcome is count of participants reporting yes. | 12 days post-baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |